NeoGenomics, Inc.
US ˙ NasdaqCM ˙ US64049M2098

SecurityNEO / NeoGenomics, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership2,674,335 shares
Latest Disclosed Value $ 19,841,941
Dimensional Fund Advisors Lp reports 9.21% increase in ownership of NEO / NeoGenomics, Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 2,674,335 shares of NeoGenomics, Inc. (US:NEO) valued at $19,843,566 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 2,448,747 shares of NeoGenomics, Inc.. This represents a change in shares of 9.21% during the quarter. The current value of the position is $29,150,252 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F NEOGENOMICS COM NEW 64049M209 2,674,335 225,588 9.21 19,842 -31.11 0.0009
2026-02-12 2025-12-31 13F NEOGENOMICS COM NEW 64049M209 2,448,747 -1,379,066 -36.03 28,801 -2.53 0.0060
2025-11-12 2025-09-30 13F NEOGENOMICS COM NEW 64049M209 3,827,813 -465,844 -10.85 29,551 -5.85 0.0063
2025-08-12 2025-06-30 13F NEOGENOMICS COM NEW 64049M209 4,293,657 448,528 11.66 31,386 -13.99 0.0073
2025-05-13 2025-03-31 13F NEOGENOMICS COM NEW 64049M209 3,845,129 408,271 11.88 36,490 -35.58 0.0091
2025-02-13 2024-12-31 13F NEOGENOMICS COM NEW 64049M209 3,436,858 78,211 2.33 56,645 14.35 0.0136
2024-11-07 2024-09-30 13F NEOGENOMICS COM NEW 64049M209 3,358,647 34,023 1.02 49,537 7.44 0.0120
2024-08-09 2024-06-30 13F NEOGENOMICS COM NEW 64049M209 3,324,624 217,687 7.01 46,108 -5.60 0.0120
2024-05-10 2024-03-31 13F NEOGENOMICS COM NEW 64049M209 3,106,937 100,414 3.34 48,841 0.39 0.0132
2024-02-07 2023-12-31 13F NEOGENOMICS COM NEW 64049M209 3,006,523 18,603 0.62 48,650 32.37 0.0142
2023-11-09 2023-09-30 13F NEOGENOMICS COM NEW 64049M209 2,987,920 7,546 0.25 36,754 -23.26 0.0121
2023-08-09 2023-06-30 13F NEOGENOMICS COM NEW 64049M209 2,980,374 287,767 10.69 47,895 2.17 0.0153
2023-05-12 2023-03-31 13F NEOGENOMICS COM NEW 64049M209 2,692,607 902,024 50.38 46,880 292,893.75 0.0158
2023-02-09 2022-12-31 13F NEOGENOMICS COM NEW 64049M209 1,790,583 816,712 83.86 17 -99.81 0.0049
2022-11-10 2022-09-30 13F NEOGENOMICS COM NEW 64049M209 973,871 -250,303 -20.45 8,385 -15.96 0.0032
2022-08-12 2022-06-30 13F NEOGENOMICS COM NEW 64049M209 1,224,174 -191,804 -13.55 9,977 -42.02 0.0036
2022-05-13 2022-03-31 13F NEOGENOMICS COM 64049M209 1,415,978 -119,878 -7.81 17,207 -67.16 0.0053
2022-02-09 2021-12-31 13F NEOGENOMICS COM 64049M209 1,535,856 154,691 11.20 52,403 -21.35 0.0158
2021-11-12 2021-09-30 13F NEOGENOMICS COM 64049M209 1,381,165 314,094 29.44 66,630 38.23 0.0215
2021-08-12 2021-06-30 13F NEOGENOMICS COM 64049M209 1,067,071 146,755 15.95 48,203 8.47 0.0153
2021-05-14 2021-03-31 13F NEOGENOMICS COM 64049M209 920,316 -273,883 -22.93 44,437 -30.89 0.0147
2021-03-08 2020-12-31 13F/A-2 NEOGENOMICS COM 64049M209 1,194,199 -113,918 -8.71 64,297 33.24 0.0232
2021-02-11 2020-12-31 13F NEOGENOMICS COM 64049M209 1,194,199 -113,918 64,297 23,220.6588
2020-11-12 2020-09-30 13F NEOGENOMICS COM 64049M209 1,308,117 -55,243 -4.05 48,256 14.27 0.0205
2020-08-13 2020-06-30 13F NEOGENOMICS COM 64049M209 1,363,360 -207,318 -13.20 42,230 -2.62 0.0186
2020-05-14 2020-03-31 13F NEOGENOMICS COM 64049M209 1,570,678 106,045 7.24 43,366 1.23 0.0226
2020-02-14 2019-12-31 13F NEOGENOMICS COM 64049M209 1,464,633 5,147 0.35 42,840 53.52 0.0156
2019-11-12 2019-09-30 13F NEOGENOMICS COM 64049M209 1,459,486 55,921 3.98 27,905 -9.38 0.0108
2019-08-13 2019-06-30 13F NEOGENOMICS COM 64049M209 1,403,565 141,408 11.20 30,793 19.26 0.0120
2019-08-12 2019-03-31 13F/A-2 NEOGENOMICS COM 64049M209 1,262,157 123,916 10.89 25,821 79.91 0.0103
2019-05-10 2019-03-31 13F NEOGENOMICS COM 64049M209 1,262,157 123,916 25,821
2019-02-26 2018-12-31 13F/A-1 NEOGENOMICS COM 64049M209 1,138,241 172,451 17.86 14,352 -3.19 0.0065
2019-02-13 2018-12-31 13F NEOGENOMICS COM 64049M209 1,138,241 172,451 14,352
2018-11-13 2018-09-30 13F NEOGENOMICS COM 64049M209 965,790 212,937 28.28 14,825 50.20 0.0056
2018-08-10 2018-06-30 13F NEOGENOMICS COM 64049M209 752,853 165,451 28.17 9,870 105.93 0.0039
2018-05-11 2018-03-31 13F NEOGENOMICS COM 64049M209 587,402 -7,481 -1.26 4,793 -9.07 0.0020
2018-02-12 2017-12-31 13F NEOGENOMICS COM 64049M209 594,883 -7,923 -1.31 5,271 -21.43 0.0022
2017-11-13 2017-09-30 13F NEOGENOMICS COM 64049M209 602,806 -46,254 -7.13 6,709 15.35 0.0029
2017-08-11 2017-06-30 13F NEOGENOMICS COM 64049M209 649,060 244,434 60.41 5,816 82.21 0.0027
2017-05-12 2017-03-31 13F NEOGENOMICS COM 64049M209 404,626 256,282 172.76 3,192 151.14 0.0015
2017-02-09 2016-12-31 13F NEOGENOMICS COM 64049M209 148,344 148,344 1,271 0.0006
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.